Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc.（SBFM）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · SBFM · 截至 2026年6月9日
活动摘要
买入笔数
3
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Sunshine Biopharma, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
SBFM 季度内部人买卖趋势
SBFM 内幕交易卖出 · SBFM 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · SBFM CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
SBFM 高管卖出股份 · SBFM 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 14, 2026 | NATAN DAVID Director | Award | 100,000 | — | Form 4 |
| Nov 30, 2022 | Sebaaly Camille CFO/Secretary | Purchase | 30,000 | $23K | Form 4 |
| Jun 3, 2022 | Sebaaly Camille CFO/Secretary | Purchase | 25,000 | $31K | Form 4 |
| Jan 6, 2021 | MERZOUKI ABDERRAZZAK COO · Director | Award | 20,000,000 | $20K | Form 4 |
| Jan 6, 2021 | Slilaty Steve N. CEO · Director | Award | 20,000,000 | $20K | Form 4 |
| Jan 6, 2021 | Sebaaly Camille CFO/Secretary · Director | Award | 20,000,000 | $20K | Form 4 |
| Dec 19, 2019 | Sebaaly Camille CFO/Secretary · Director | Award | 1,300,000 | $1K | Form 4 |
| Oct 20, 2019 | Sebaaly Camille CFO/Secretary · Director | Award | 1,100,000 | $1K | Form 4 |
| Sep 11, 2019 | Sebaaly Camille CFO/Secretary · Director | Award | 550,000 | $550 | Form 4 |
| Dec 31, 2019 | Sebaaly Camille CFO/Secretary · Director | Award | 323,673 | $324 | Form 4 |
| Dec 19, 2019 | MERZOUKI ABDERRAZZAK COO · Director | Award | 1,300,000 | $1K | Form 4 |
| Oct 20, 2019 | MERZOUKI ABDERRAZZAK COO · Director | Award | 1,100,000 | $1K | Form 4 |
| Dec 19, 2019 | Slilaty Steve N. CEO · Director | Award | 1,300,000 | $1K | Form 4 |
| Oct 20, 2019 | Slilaty Steve N. CEO · Director | Award | 1,100,000 | $1K | Form 4 |
| Dec 31, 2019 | Slilaty Steve N. CEO · Director | Other | 323,673 | $324 | Form 4 |
| Sep 2, 2019 | MERZOUKI ABDERRAZZAK COO · Director | Award | 13,000,000 | $13K | Form 4 |
| Sep 11, 2019 | Sebaaly Camille Secretary · Director | Award | 11,000,000 | $11K | Form 4 |
| Sep 2, 2019 | Sebaaly Camille Secretary · Director | Award | 13,000,000 | $13K | Form 4 |
| Sep 2, 2019 | Slilaty Steve N. CEO · Director | Award | 13,000,000 | $13K | Form 4 |
| Aug 27, 2018 | MERZOUKI ABDERRAZZAK COO · Director | Award | 38,000,000 | $38K | Form 4 |
| Aug 27, 2018 | Sebaaly Camille Secretary · Director | Award | 38,000,000 | $38K | Form 4 |
| Aug 27, 2018 | Slilaty Steve N. CEO · Director | Award | 38,000,000 | $38K | Form 4 |
| Jun 20, 2018 | MERZOUKI ABDERRAZZAK COO · Director | Award | 27,000,000 | $27K | Form 4 |
| Jun 20, 2018 | Sebaaly Camille Secretary · Director | Award | 27,000,000 | $27K | Form 4 |
| Jun 20, 2018 | Slilaty Steve N. CEO · Director | Award | 27,000,000 | $27K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 SBFM 内幕交易
SBFM 内幕交易
Sunshine Biopharma, Inc.（SBFM）内幕交易数据来源于公司内部人（包括NATAN DAVID (Director)）提交的SEC Form 4申报文件。过去12个月内，1位内部人向SEC提交了交易申报。SBFM内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Sunshine Biopharma, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
SBFM 内幕交易 · 5个问题Sunshine Biopharma, Inc.（SBFM）的内部人包括高管和董事，如NATAN DAVID (Director)等。过去12个月内，1位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026